OMEZIE MOLOKWU: Open Payments
NPI 1093322935 · LAKEHURST, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 35 payments from 11 companies in 2025. Trend: 2023 $709 · 2024 $566 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $97 |
| Alkermes, Inc. | 5 | $92 |
| Axsome Therapeutics, Inc. | 5 | $90 |
| Janssen Pharmaceuticals, Inc | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| ABBVIE INC. | 3 | $44 |
| Almatica Pharma LLC | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: FANAPT, ARISTADA, Auvelity, SPRAVATO, TRINTELLIX, REXULTI, CAPLYTA, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
